DFDA

Probiotics (Lactobacillus rhamnosus GG / Saccharomyces boulardii)

Treatment for Diarrheal Diseases

Typical Dosage: 5-20 billion CFU daily

Effectiveness
75%
Safety Score
85%
Clinical Trials
500
Participants
80K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
5-20 billion CFU daily
Time to Effect
days to weeks
Treatment Duration
days to weeks for acute, ongoing for prevention
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$800
Side Effect Mgmt:$0
Total Annual:$1,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$30,000/QALY
QALYs Gained
0.03
Outcome-Based Costs
Cost per Responder
$333.33
Probiotics (Lactobacillus rhamnosus GG / Saccharomyces boulardii) Outcomes

for Diarrheal Diseases

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+60%
Common Side Effects
Bloating
+5%
Gas
+5%
Mild abdominal discomfort
+3%
Fungemia/Bacteremia (in immunocompromised)
+0.01%

Sources:

nih.gov
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov